Production (Stage)
Coeptis Therapeutics Holdings, Inc.
COEP
$8.23
-$0.13-1.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.27M | 532.90K | 1.14M | 1.56M | 1.03M |
| Total Receivables | -- | -- | -- | 191.10K | 108.60K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 382.60K | 518.40K | 227.20K | 244.80K | 242.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 4.65M | 1.05M | 1.36M | 1.99M | 1.38M |
|
|
|||||
| Total Current Assets | 4.65M | 1.05M | 1.36M | 1.99M | 1.38M |
| Net Property, Plant & Equipment | 60.10K | 70.20K | 80.20K | 90.00K | 99.50K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 496.70K | 541.90K | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.30M | 1.55M | 1.82M | 2.12M | 2.42M |
| Total Assets | 13.45M | 8.91M | 8.96M | 4.20M | 3.89M |
|
|
|||||
| Total Accounts Payable | 1.12M | 1.27M | 1.13M | 1.28M | 1.37M |
| Total Accrued Expenses | 602.40K | 736.90K | 742.20K | 771.00K | 719.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.87M | 1.23M | 1.56M | 1.57M | 2.22M |
| Total Finance Division Other Current Liabilities | 2.06M | 1.28M | -- | -- | -- |
| Total Other Current Liabilities | 2.06M | 1.28M | -- | -- | -- |
| Total Current Liabilities | 5.65M | 4.51M | 3.44M | 3.63M | 4.30M |
|
|
|||||
| Total Current Liabilities | 5.65M | 4.51M | 3.44M | 3.63M | 4.30M |
| Long-Term Debt | 150.00K | 150.00K | 150.00K | 150.00K | 150.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 18.90K | 18.90K | 61.20K | 61.20K | 61.20K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 169.10K | 359.30K | 322.10K | 671.60K | 522.40K |
| Total Liabilities | 5.99M | 5.04M | 3.97M | 4.51M | 5.04M |
|
|
|||||
| Common Stock & APIC | 108.38M | 102.98M | 102.15M | 100.50M | 94.72M |
| Retained Earnings | -101.65M | -98.23M | -95.22M | -93.39M | -90.36M |
| Treasury Stock & Other | -250.00K | -1.56M | -2.10M | -7.55M | -5.50M |
| Total Common Equity | 6.48M | 3.19M | 4.82M | -442.60K | -1.14M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00 | 0.00 | 0.00 | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | -- | -- |
|
|
|||||
| Total Common Equity | 6.48M | 3.19M | 4.82M | -442.60K | -1.14M |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | -- | -- |
| Total Minority Interest | 984.30K | 682.10K | 157.70K | 132.50K | -- |
| Total Equity | 7.46M | 3.87M | 4.98M | -310.10K | -1.14M |
|
|
|||||